ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs

Published July 30, 2010

ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs
NEW YORK–(BUSINESS WIRE)–ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a biopharmaceutical cancer company addressing unmet medical needs, today reported its financial results for the three months ended June 30, 2010 and provided an update on the Company’s continued progress with its clinical programs. For the second quarter of 2010, the Company’s cash used in operations was $ 4.3 million, an increase …
Read more on Business Wire

Macey’s sponsors drug drop off event
“Crush them and flush them“ used to be the way to dispose of old and unneeded medications, but now Cache Valley residents are being encouraged to turn them over to the police.
Read more on Cache Valley Daily

GSK anticipates to supply over 30 million doses of FLULAVAL, FLUARIX for 2010-2011 flu season
GlaxoSmithKline announced today that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has released the first lots of FluLaval® [Influenza Virus Vaccine] allowing distribution in the U.S. to begin for the 2010-2011 flu season. GSK anticipates distribution of Fluarix® [Influenza Virus Vaccine] to follow in the next several weeks.
Read more on News-Medical-Net